Search
for
Sort by
Research 91–120 of 1000+
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment
- BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis
- Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia
- Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
- 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata
- Intralesional Methotrexate Is Comparable to Triamicinolone Acetonide and Superior to Vitamin D3 in the Treatment of Alopecia Areata
- BH31 Dermoscopic analysis of patients with and without poor prognostic indicators in alopecia areata: a comparative study
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- Evaluation of Hair Regrowth after Minoxidil and Dutasteride Tattooing in Men with Androgenetic Alopecia
- Deficient and/or insufficient serum 25 hydroxy vitamin D in patients with alopecia areata: is it a fact or a fiction?
- Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study
- COMPARISON OF CLINICAL EFFICACY OF TOFACITINIB VERSUS METHOTREXATE IN SEVERE ALOPECIA AREATA, ALOPECIA TOTALIS, AND ALOPECIA UNIVERSALIS: A RANDOMIZED CONTROLLED TRIAL
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Advancing Hair Loss Assessment in Alopecia Areata: The Mathematical Case for Centralised, Standardised Imaging
- Efficacy of Intralesional Triamcinolone Acetonide Combined With Cryotherapy Compared to Intralesional Triamcinolone Acetonide Alone in Treating Limited Patchy Alopecia Areata of the Scalp and Face: A Prospective, Randomized, Within‐Subject Controlled Trial
- Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24‐Week Outcomes From a Prospective Real‐World Cohort
- Clinical Trial Eligibility in Real‐World Alopecia Areata Patients Treated With Baricitinib
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series
- Tofacitinib in the Recalcitrant Cases of Alopecia Areata: A Pilot Study
- JAK Inhibitors in African American Patients With Alopecia Areata: A Case Series
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Bempikibart shows its potential for hair regrowth in alopecia areata